Ascentage Pharma Group International Financial Overview
Ascentage Pharma Group International's market cap is currently HK$19.85B. The company's EPS TTM is HK$-1.8983668943599998; its P/E ratio is -13.67; Ascentage Pharma Group International is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is HK$-0.82. See an overview of income statement, balance sheet, and cash flow financials.
